Prulifloxacin
Prulifloxacin, identified by CAS number 123447-62-1, is a synthetic broad-spectrum antibacterial agent belonging to the fluoroquinolone class. Structurally, it is a prodrug of ulifloxacin, featuring a thiazolo-oxoquine carboxylic acid framework. This chemical is valued in high-level laboratory settings for its specific inhibitory action against bacterial DNA synthesis. It typically presents as a crystalline solid and exhibits stability under standard storage conditions when protected from excessive light and moisture.
In the context of chemical research and development, Prulifloxacin serves as a critical reference material for analytical testing and structural characterization. Its unique molecular architecture makes it a subject of interest for medicinal chemistry studies focusing on the structure-activity relationships of quinolone derivatives. Researchers utilize this compound to explore pharmacokinetic profiles and the mechanisms of metabolic activation within complex biological systems.
• Prulifloxacin is extensively utilized as a primary reference standard in analytical chemistry for the development and validation of high-performance liquid chromatography (HPLC) and mass spectrometry methods. These applications ensure precise quantification and purity assessment during the synthesis and manufacturing processes of related heterocyclic compounds.
• The compound serves as a vital tool in microbiological research and in vitro susceptibility testing. It allows scientists to investigate the mechanisms of bacterial resistance and the potency of fluoroquinolone-based scaffolds against various microbial strains, contributing to the broader understanding of enzymatic inhibition in prokaryotic cells.
• In the field of pharmacokinetics and metabolic studies, Prulifloxacin is employed to model the conversion of prodrugs into their active metabolites. Researchers use it to study the enzymatic hydrolysis processes and the subsequent distribution of the active moiety, providing insights into the chemical behavior of complex organic molecules in simulated physiological environments.
• It is also used as a starting material or intermediate in the synthesis of derivative compounds for chemical library expansion. Its specific functional groups allow for further chemical modifications, enabling the exploration of novel molecular entities within the thiazolo-quinoline chemical space for industrial and academic research purposes.
Product Name: Prulifloxacin
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.